Clinical Trials Browser

Interventional × Observation × Genitourinary × Clear all

NCT04216290 2026-05-22

A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial

Phase 2 Active not recruiting

Urinary Bladder Neoplasms

NCT06733350 2026-05-14

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

Phase 4 Recruiting

Prostatic Neoplasms

NCT06401330 2026-05-05

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

Phase 3 Recruiting

Stage I Mixed Cell Type Kidney Wilms Tumor

NCT03055013 2026-05-04

Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

Phase 3 Active not recruiting

819 enrolled 12 charts

Carcinoma, Renal Cell

NCT01251861 2026-04-29

Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer

Phase 2 Active not recruiting

108 enrolled 16 charts

Prostatic Neoplasms

NCT06378866 2026-04-20

DIVINE

Phase 2 Recruiting

Prostatic Neoplasms

NCT06378346 2026-02-23

GU-01

Phase 2 Recruiting

Prostatic Neoplasms

NCT04519879 2025-10-29

White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT06200103 2025-09-11

Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms

NCT00002668 2023-06-22

Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer

Phase NA Terminated

BreastGenitourinary

Breast Neoplasms, Pain, Prostatic Neoplasms

NCT05493956 2022-09-09

RACE-GB

Phase NA Unknown

GastrointestinalGenitourinary

Gallbladder Cancer Unresectable

NCT02614859 2022-03-29

BIMET-1

Phase 2 Completed

29 enrolled 10 charts

Prostatic Neoplasms

NCT00887432 2021-10-26

Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation

Phase NA Completed

132 enrolled 11 charts

Prostate Adenocarcinoma

NCT02700724 2018-08-13

Observation Versus Immediate Surgery of Low Risk Bladder Cancer

Phase NA Terminated

Urinary Bladder Neoplasms

NCT00118066 2015-05-27

Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia

Phase 2 Terminated

GenitourinaryOther neoplasm

Precancerous Conditions, Prostatic Neoplasms

NCT00445731 2014-09-08

A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant

Phase NA Completed

BreastCNSDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Carcinoma, Ovarian Epithelial, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myeloproliferative Disorders, Neoplasms, Neuroblastoma, Sezary Syndrome, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis